Chirhostim Injection, Powder, Lyophilized, For Solution
Product Images NDC 67066-005

4 FDA label images from Chirhoclin, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chirhostim (NDC 67066-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chirhoclin, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Box (005lb517)

Label Box (005lb517)
Packaging label for ChiRhoStim 16 mcg/vial, a human secretin injection in lyophilized powder form by ChiRhoClin, Inc. The label includes dosage information, storage instructions to keep the product frozen before reconstitution, and single-use warnings. It displays the product name, strength, vial contents, barcode, and manufacturer details with a distinct pink ChiRhoStim logo.*
FDA Label Image

Label Vial (005lv517)

Label Vial (005lv517)
Label for ChiRhoStim 40, Human Secretin for Injection, 16 mcg/vial. The label includes the product name in purple, the dosage strength, route (intravenous), and usage instructions as a lyophilized powder for single use. It also displays information about constituents, storage instructions, and reconstitution with Sodium Chloride Injection USP. The label features the ChiRhoClin, Inc. logo and mentions the manufacturing location in Burtonsville, MD. A barcode is also present at the bottom.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A scatter plot titled 'Chronic Pancreatitis Patients and Healthy Subjects' comparing sHS Peak Bicarbonate (mEq/L) on the x-axis with bPS Peak Bicarbonate (mEq/L) on the y-axis. The chart includes data points for Chronic Pancreatitis - Sick Patients (open squares), Chronic Pancreatitis - Recovered Patients (open triangles), and Healthy Subjects (solid circles). Two dashed reference lines at 80 mEq/L are shown on both axes, with an additional linear trend line. The bottom right notes dosing of sHS 0.2 mcg/kg and bPS 1 CU/kg.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
Scatter plot titled 'Chronic Pancreatitis Patients and Healthy Subjects' comparing sHS Peak Bicarbonate (mEq/L) on the x-axis and sPS Peak Bicarbonate (mEq/L) on the y-axis. Data points differentiate Chronic Pancreatitis sick patients (squares), recovered patients (triangles), and healthy subjects (circles). The plot includes horizontal and vertical dashed reference lines near 80 mEq/L and a diagonal line indicating correlation between the two measurements. Doses of sHS and sPS are noted as 0.2 mcg/kg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.